5-Year Follow-Up of Advanced Therapy Use in High-Risk Diabetic Foot Ulcers
Background/Objectives: Advanced wound healing biologics for diabetic foot ulcer (DFU) are typically withheld from persons who are at high risk for amputation. However, a prospective, single-center cohort study evaluated the use of an advanced biologic, dehydrated amniotic (DAMA) tissue as early trea...
Saved in:
| Main Authors: | Margaret Doucette, Stephanie Seabolt, Kattie Payne, Jeremy Boyd |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Diabetology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4540/6/7/61 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution after toe amputation related to diabetic foot
by: José Maria Pereira de Godoy, et al.
Published: (2024-12-01) -
Electrochemical skin conductance: a tool for risk stratification and early anticipation of diabetic foot ulcers
by: Jean-François Gautier, et al.
Published: (2025-03-01) -
Feet at risk of development of ulcerations and amputations in diabetics
by: Magnollya Moreno de Araujo, et al.
Published: (2009-04-01) -
Diabetic Foot: Old Disease, New Challenges
by: Dobromir Nguen, et al.
Published: (2023-07-01) -
Risk factors affecting the development of adverse outcomes in patients with diabetic foot infection
by: Rukiye İnan Sarikaya, et al.
Published: (2025-04-01)